Skip to main content
. 2022 Mar 24;14(7):1644. doi: 10.3390/cancers14071644

Table 2.

Rate and Time to Continence.

Cohort 6-Month Continence Rate (95% CI) 12-Month Continence Rate (95% CI) 24-Month Continence Rate (95% CI) Median Time to Continence (95% CI)
Perfect Continence
Overall 23% (20–26) 49% (45–53) 64% (61–68) 12.1 (11.7–13)
Model Development 23% (20–27) 48% (44–52) 63% (58–67) 12.5 (11.8–14)
Model Validation 21% (15–29) 54% (45–62) 71% (52–68) 11.6 (8.0–12.5)
Social Continence
Overall 74% (70–77) 93% (91–95) 97% (96–98) 2.4 (2.0–2.9)
Model Development 74% (70–77) 93% (91–95) 98% (96–99) 2.5 (2.0–3.3)
Model Validation 75% (67–82) 92% (87–96) 97% (93–99) 1.9 (1.8–2.9)

Time reported in months; CI = confidence interval.